Quantcast

Latest TGen Drug Development Services Stories

bc4bf19b16853d9be5f8a4e69efde1051
2010-04-15 09:08:01

TGen and VARI study cancer in dogs to find new treatments for humans Fido's wet licks might hold more than love. They could provide the DNA keys to findings new treatments for rare cancers and other diseases in both dogs and human patients. The Translational Genomics Research Institute (TGen) and the Van Andel Research Institute (VARI) have created the Canine Hereditary Cancer Consortium, a program designed to study naturally occurring cancers in dogs to better understand why both pets and...

2008-08-05 06:00:46

Apthera, Inc., a Scottsdale, Arizona-based biotechnology company focused on cancer immunotherapy, today announced an alliance with TGen Drug Development Services (TD2) under a Master Services Agreement. TD2 will provide key drug development and regulatory services related to the clinical development of NeuVax(TM), Apthera's lead immunotherapy drug indicated for the adjuvant treatment of early-stage, lymph-node-positive breast cancer that contains the HER2 oncogene. Apthera is currently...


Word of the Day
omphalos
  • The navel or umbilicus.
  • In Greek archaeology: A central boss, as on a shield, a bowl, etc.
  • A sacred stone in the temple of Apollo at Delphi, believed by the Greeks to mark the 'navel' or exact center-point of the earth.
'Omphalos' comes from the ancient Greek.
Related